Vanguard Group Inc. Increases Stock Position in Colgate-Palmolive Company $CL

Vanguard Group Inc. grew its stake in Colgate-Palmolive Company (NYSE:CL) by 0.2% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 82,921,002 shares of the company’s stock after acquiring an additional 169,313 shares during the period. Vanguard Group Inc. owned about 0.10% of Colgate-Palmolive worth $6,628,705,000 as of its most recent filing with the SEC.

Several other large investors have also recently made changes to their positions in CL. Brighton Jones LLC lifted its stake in Colgate-Palmolive by 4.4% during the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after purchasing an additional 450 shares in the last quarter. Woodline Partners LP raised its holdings in shares of Colgate-Palmolive by 76.3% in the 1st quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock valued at $4,344,000 after buying an additional 20,062 shares during the period. Stratos Wealth Advisors LLC acquired a new position in Colgate-Palmolive during the 2nd quarter worth about $262,000. Sigma Investment Counselors Inc. boosted its holdings in Colgate-Palmolive by 8.7% during the 2nd quarter. Sigma Investment Counselors Inc. now owns 2,995 shares of the company’s stock valued at $272,000 after acquiring an additional 239 shares during the period. Finally, Schnieders Capital Management LLC. grew its position in Colgate-Palmolive by 2.0% in the 2nd quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock valued at $1,136,000 after acquiring an additional 245 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have recently commented on CL. JPMorgan Chase & Co. raised their price objective on shares of Colgate-Palmolive from $93.00 to $97.00 and gave the company an “overweight” rating in a research note on Monday, February 2nd. Royal Bank Of Canada raised shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price target for the company in a research report on Tuesday, December 9th. The Goldman Sachs Group restated a “buy” rating and issued a $94.00 price target on shares of Colgate-Palmolive in a research note on Saturday, January 31st. UBS Group increased their price objective on Colgate-Palmolive from $90.00 to $93.00 and gave the company a “buy” rating in a research note on Wednesday, January 14th. Finally, Barclays boosted their target price on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 3rd. Eleven analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average target price of $94.38.

Colgate-Palmolive Trading Up 0.5%

NYSE:CL opened at $96.61 on Tuesday. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $100.18. The stock has a market cap of $77.87 billion, a P/E ratio of 36.87, a P/E/G ratio of 4.36 and a beta of 0.29. The stock has a 50-day simple moving average of $84.21 and a 200-day simple moving average of $81.93.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The firm had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. During the same period in the prior year, the company posted $0.91 earnings per share. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. As a group, analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Wednesday, January 21st were paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.2%. The ex-dividend date was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 79.39%.

Insider Activity at Colgate-Palmolive

In related news, insider John Hazlin sold 20,989 shares of the firm’s stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the transaction, the insider owned 17,645 shares in the company, valued at $1,663,041.25. This trade represents a 54.33% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Panagiotis Tsourapas sold 15,000 shares of the business’s stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $97.81, for a total value of $1,467,150.00. Following the completion of the sale, the chief operating officer owned 10,415 shares of the company’s stock, valued at approximately $1,018,691.15. This represents a 59.02% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 184,683 shares of company stock valued at $17,486,693 in the last ninety days. 0.41% of the stock is currently owned by insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.